BACKGROUND: Antineoplastic phospholipids (ALPs) represent a promising class of drugs with a novel mode of action undergoes rapid turnover in the cell membrane of tumors, interfering with lipid signal transduction, inducing cell death. The aim of this study was to investigate the synthetic phosphoethanolamine (Pho-s) as a new anticancer agent. MATERIALS AND METHODS: Cell viability and morphology were assessed by (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), Hoechst and rhodamine staining. Apoptosis was assessed by Annexin V and propidium iodide (PI) staining, caspase-3 activity, mitochondrial membrane potential (ΔmΨ) and cell cycle analysis, combined with evaluation of tumor growth in Ehrlich Ascites Tumor (EAT) bearing mice. RESULTS: We found that Pho-s 2.30 mg/ml induced cytotoxicity in all tumor cell lines studied without affecting normal cells. In vitro studies with EAT cells indicated that Pho-s induced apoptosis, demonstrated by an increase in Annexin-V positive cells, loss of mitochondrial potential (ΔmΨ) and increased caspase-3 activity. It was also shown to increase the sub-G(1) apoptotic fraction and inhibit progression to the S phase of the cell cycle. Additionally, antitumor effects on the EAT-bearing mice showed that Pho-s, at a concentration of 35 and 70 mg/kg, inhibited tumor growth and increased the lifespan of animals without causing liver toxicity. CONCLUSION: These findings suggest that Pho-s is a potential anticancer candidate drug.
BACKGROUND: Antineoplastic phospholipids (ALPs) represent a promising class of drugs with a novel mode of action undergoes rapid turnover in the cell membrane of tumors, interfering with lipid signal transduction, inducing cell death. The aim of this study was to investigate the synthetic phosphoethanolamine (Pho-s) as a new anticancer agent. MATERIALS AND METHODS: Cell viability and morphology were assessed by (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), Hoechst and rhodamine staining. Apoptosis was assessed by Annexin V and propidium iodide (PI) staining, caspase-3 activity, mitochondrial membrane potential (ΔmΨ) and cell cycle analysis, combined with evaluation of tumor growth in Ehrlich Ascites Tumor (EAT) bearing mice. RESULTS: We found that Pho-s 2.30 mg/ml induced cytotoxicity in all tumor cell lines studied without affecting normal cells. In vitro studies with EAT cells indicated that Pho-s induced apoptosis, demonstrated by an increase in Annexin-V positive cells, loss of mitochondrial potential (ΔmΨ) and increased caspase-3 activity. It was also shown to increase the sub-G(1) apoptotic fraction and inhibit progression to the S phase of the cell cycle. Additionally, antitumor effects on the EAT-bearing mice showed that Pho-s, at a concentration of 35 and 70 mg/kg, inhibited tumor growth and increased the lifespan of animals without causing liver toxicity. CONCLUSION: These findings suggest that Pho-s is a potential anticancer candidate drug.
Authors: Roopali Saxena; Chunhua Yang; Mukkavilli Rao; Ravi Chakra Turaga; Chakravarthy Garlapati; Sushma Reddy Gundala; Kimberly Myers; Ahmed Ghareeb; Shristi Bhattarai; Golnaz Kamalinia; Sangina Bristi; Dan Su; Giovanni Gadda; Padmashree C G Rida; Guilherme H Cantuaria; Ritu Aneja Journal: Clin Cancer Res Date: 2017-02-06 Impact factor: 12.531
Authors: Patrícia Ferreira de Castro; Durvanei Augusto Maria; Ana Carolina Brandão de Campos Fonseca Pinto; Geni Cristina Fonseca Patricio; Julia Maria Matera Journal: Vet Med Sci Date: 2022-02-22
Authors: Adilson Kleber Ferreira; Vanessa Morais Freitas; Débora Levy; Jorge Luiz Mária Ruiz; Sergio Paulo Bydlowski; Rose Eli Grassi Rici; Otaviano Mendonça R Filho; Gilberto Orivaldo Chierice; Durvanei Augusto Maria Journal: PLoS One Date: 2013-03-14 Impact factor: 3.240
Authors: Thais Chile; Maria Angela Henriques Zanella Fortes; Maria Lúcia Cardillo Corrêa-Giannella; Helena Paula Brentani; Durvanei Augusto Maria; Renato David Puga; Vanessa de Jesus R de Paula; Marcia Saldanha Kubrusly; Estela Maria Novak; Telésforo Bacchella; Ricardo Rodrigues Giorgi Journal: BMC Cancer Date: 2013-10-02 Impact factor: 4.430
Authors: Vishal M Gohil; Lin Zhu; Charli D Baker; Valentin Cracan; Abbas Yaseen; Mohit Jain; Clary B Clish; Paul S Brookes; Marica Bakovic; Vamsi K Mootha Journal: J Biol Chem Date: 2013-10-19 Impact factor: 5.157
Authors: Arthur Cássio de Lima Luna; Greice Kelle Viegas Saraiva; Otaviano Mendonça Ribeiro Filho; Gilberto Orivaldo Chierice; Salvador Claro Neto; Iolanda Midea Cuccovia; Durvanei Augusto Maria Journal: Int J Nanomedicine Date: 2016-04-18